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Abstract 
Introduction: The project consists of a World Wide Web (WWW) site that can be accessed by . all 
interested individuals knowledgeable in WWW operating protocol. The design is of an informational 
reference source to aid the practicing clinician and the optometric student in gathering cross-referenced 
information regarding a particular ocular disease. This project did not develop the entire reference base 
for all ocular disease conditions, but rather developed a generic template using bacterial conjunctivitis as 
an example. Using the established protocol, additional ocular disease conditions will be added in the 
future to complete the site. 
Methods: Microsoft Frontpage 97 was used to create a World Wide Web (WWW) site consisting of six 
separate but interrelated pages. The six main sections of the ocular disease web site include; pathology 
and disease conditions, diagnostic techniques, differential diagnosis, causative agents, pharmacology, 
and references. Information on each topic section was derived from multiple reference sources including 
current text books, journal articles and class notes. Each page has detailed text information, full color 
images of the various conditions, as well as helpful visual information to reinforce text information. 
Crossed reference links were built to allow the user to easily access related information contained in the 
other topic pages. Even though this project is self contained, it has built-in links to various optometric and 
related medical information sites. 
Results: The project was presented to local practitioners where it received positive praise. The web site 
was uploaded to the Pacific University College of Optometry home page. Testing and evaluation of the 
performance is currently being conducted. 
Discussion: Use of the World Wide Web as a source of information IS still in its infancy. The potential for 
practitioners of Optometry to access this vast wealth information in a rapid and efficient manner is just 
beginning to be realized The strength of this format is the ability to access all related information 
contained in any other page by simply clicking a button. 
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Abstract 
Introduction: The project consists of a World Wide Web (WWW) 
site that can be accessed by . all interested individuals 
knowledgeable in WWW operating protocol. The design is of an 
informational reference source to aid the practicing clinician and 
the optometric student in gathering cross-referenced information 
regarding a particular ocular disease. This project did not develop 
the entire reference base for all ocular disease conditions, but 
rather developed a generic template using bacterial conjunctivitis 
as an example. Using the established protocol, additional ocular 
disease conditions will be added in the future to complete the site. 
Methods: Microsoft Frontpage 97 was used to create a World Wide 
Web (WWW) site consisting of six separate but interrelated pages. 
The six main sections of the ocular disease web site include; 
pathology and disease conditions, diagnostic techniques, 
differential diagnosis, causative agents, pharmacology, and 
references. Information on each topic section was derived from 
multiple reference sources including current text books, journal 
articles and class notes. Each page has detailed text information, 
full color images of the various conditions, as well as helpful 
visual information to reinforce text information. Crossed 
reference links were built to allow the user to easily access 
related information contained in the other topic pages. Even 
though this project is self contained, it has built-in links to various 
optometric and related medical information sites. 
Results: The project was presented to local practltwners where it 
received positive praise. The web site was uploaded to the Pacific 
University College of Optometry home page. Testing and 
evaluation of the performance is currently being conducted. 
Discussion: Use of the World Wide Web as a source of 
information IS still in its infancy. The potential for practitioners of 
Optometry to access this vast wealth information in a rapid and 
efficient manner is just beginning to be realized The strength of 
this format is the ability to access all related information 
contained in any other page by simply clicking a button. 
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Introduction 
Advancements occurnng m technology and communications are 
creating new methods for efficiently obtaining a wide range of 
information. The World Wide Web (WWW) allows people from all 
around the globe the opportunity to access educational information 
in a highly organized and rapid manner. This project provides 
optometry with an informational reference source on ocular disease 
that is accessible through the WWW. The informational reference 
source was designed for practicing optometrists and optometric 
students who are either trying to acquire this information for the 
first time or who are just trying to strengthen their existing 
knowledge. This reference source will be different from other 
existing sources due to the unique properties of the WWW. Ease of 
access, availability, interactiveness, updatability and multimedia 
aspects highlights the inherent features of this medium. This project 
did not attempt to develop the entire informational reference source 
covering all topics of ocular disease, but rather the design of a 
generic template using bacterial conjunctivitis as an example. This 
template will serve as the basic design layout for future topics in 
ocular disease. The template designed includes such topics as; 
disease conditions, treatment, etiology, epidemiology, subjective 
findings, objective findings, differential diagnosis, prevention, 
sources of infection, natural defense mechanisms, pharmacology 
(including indications, contraindications, administration, and 
precautions), diagnostic techniques (including when to culture, media 
types, identification tests, and how to take samples of the cornea, 
eyelid and conjunctival tissue), classification of the causative 
organisms, and references. Incorporated into the template design 
are illustrations and graphics to aid in visual learning. Links to both 
related topics as well as to WWW search engines that allow access to 
related articles on the subject are contained within the template. All 
topics are cross referenced allowing the user to gather more 
information with greater ease than currently available via standard 
reference sources. 
Methods 
Text information was first gathered and organized using 
Microsoft Word 5 .1. Pictures and graphics were gathered and 
scanned using a Nikon Coolscan color scanner. Images were stored 
and edited using Adobe Photoshop, Text, pictures, and graphics were 
then merged together using Microsoft Frontpage 97. 
The bacterial conjunctivitis information reference source World 
Wide Web (WWW) site consists of six separate but interrelated 
pages. The six main sections of the ocular disease web site include; 
pathology and disease conditions, diagnostic techniques, differential 
diagnosis, causative agents, pharmacology, and references. 
Information on each topic section was derived from multiple 
reference sources including current text books, journal articles and 
class notes. Each page has detailed text information, full color images 
of the various conditions, as well as helpful visual information to 
reinforce text information. Crossed reference links were built to 
allow the user to easily access related information contained in the 
other topic pages. Even though this project is self contained, it has 
built-in links to various optometric and related medical information 
sites. 
This completed product was then uploaded to the Pacific 
University College of Optometry Web site. 
Discussion 
The web site can be accessed from either the Pacific University 
College of Optometry home page or by typing the URL 
www.pacificu.edu/up/opt/welcome.html into a web browser. Either 
of these two methods will present the user with the home page for 
the bacterial conjunctivitis reference source (figure 1). From this 
home page, the user can then choose which section that they wish to 
explore by clicking the computer cursor over one of the s1x 
highlighted words surrounding the eyeball at the bottom of the page. 
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Figure 1 
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This will move them to the appropriate section. The organizational 
structure of the web site is based around six main sections: Main 
Page, Pharmacology, Diagnostic Techniques, Differential Diagnosis, 
Bacteria and References. These are summarized in Appendix 1. 
The Main Page (figure 2) consists of ten sections. The first 
section, Etiology, discusses the general etiology for acute , hyperacute, 
and chronic bacterial conjunctivitis. The second and third section, 
General epidemiology and General signs and symptoms, respectively 
provide a generalized overv1ew of the condition bacterial 
conjunctivitis. The fourth section, Prevention, discusses procedures 
the patient and the doctor can do to minimize the chance of infection. 
Natural defense mechanisms of the eye and body are discussed in 
the fifth section. Section six, Sources for infection, relates to the 
common vectors and methods that bacteria are introduced to the eye. 
Section seven through ten deal with the various forms in which 
bacterial conjunctivitis can occur. Acute bacterial conjunctivitis, 
Hyperacute bacterial conjunctivitis , Chronic bacterial conjunctivitis, 
and Neonatal bacterial conjunctivitis are each individually discussed. 
Information contained on each form includes specific details as to the 
cause, subjective findings, objective findings, treatment, and follow -
up protocols. 
Figure 2 
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The Pharmacology Page (figure 3) consists of five sections. The 
first section, Treatment , discusses the different general treatment 
options. Indications and Contraindications are discussed next. 
Pharmacological Precautions are discussed fourth and Administration 
of drops, ointment and solution fifth. Lastly, the Effectiveness of 
specific drugs against specific bacteria are discussed . 
Figure 3 
Pharmacology 
The Diagnostic Techniques Page (figure 4) consists of four 
sections. The section entitled When to culture offers clinical 
guidelines to aid in the decision process of if culturing is required. 
The Media types section discusses the different types of media and 
the pathogens that they selectively culture. How to take samples 
section discusses the proper procedure for taking eyelid, 
conjunctival, and corneal samples. Identification test section 
discusses how to perform and interpret some of the specific tests 
used to differentiate bacteria with similar characteristics. 
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The Differential Diagnosis Page (figure 5) discusses characteristics of 
thirty - three separate pathologies that can cause similar symptoms 
and signs found in bacterial conjunctivitis. It also discusses how to 
differentiate between these pathologies and bacterial conjunctivitis. 
These pathologies are adenovirus, allergic, blepharoconjunctivitis, 
chlamydia, contact lens related reaction, drug induced, dry eye 
syndrome, epidemic keratoconjunctivitis, episcleritis, foreign - body 
reaction, fungal conjunctivitis, giant papillary conjunctivitis, acute 
angle closure glaucoma, herpes simplex, herpes zoster, 
hypersensitivity reaction, keratoconjunctivitis, lid deformities, 
Molluscum contagiosum, ocular rosacea, pharyngoconjunctival fever, 
phlyctenular reaction, pinguecula, scleritis, sexually transmitted 
disease, subconjunctival hemorrhage, Kawasaki disease, leptospirosis, 
Stevens-Johnson's syndrome, tear film abnormalities, trichiasis, toxic 
reaction, and vernal keratoconj uncti vi tis. 
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The Bacteria Page (figure 6) consists of four sections . The first 
section discusses Classification by shape and Gram stain. The next 
two sections discuss the Normal flora and the Pathogens that have 
been found in the conjunctiva. The Identification techniques and 
Diagnostic test section are identical to that found on the Diagnostic 
Techniques Page. 
Figure 6 
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The References Page (figure 7) details the different textbooks. 
journal articles and class notes that were used for this project. 
Figure 7 
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As a specific example, lets follow the procedure of a user 
wanting to find out treatment options for hyperacute bacterial 
conjunctivitis. The user would start by accessing the Bacterial 
Conjunctivitis home page by the method described above. After the 
home page has appeared on the screen, the user would then click 
upon Main Page. The next screen to appear would be figure 8. 
Figure 8 
From the Main Page the user would click upon Hyperacute . This 
would in turn make the section dealing with hyperacute bacterial 
conjunctivitis appear on the screen (figure 9) . For this example the 
user would then select Treatment. This will bring them to figure 10 . 
If the user was unsure of the causative organism they would next 
select Unidentified pathogen. This would then bring the user to 
figure 11 which lists the different treatment options. Should specific 
information of one of the drugs listed be needed, for example 
Gentamicin, this would be accessible by clicking that highlighted drug 
name. With this done the information for Gentamicin would then 
appear, figure 12 . 
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Figure 9 
Hyperacute Bacterial Conjunctivitis 
Subjective Fi.udinas/ Obtectiv\7 findings/ Treal.:tueut/ Follow lJf.l/ Causl;ls 
Subjective Findings of Hyperacute Bacterial Conjnncu~vitis 
Findings are simil:•r to acute bacte1·ial conjunctivitis but worse. 
First symptom is a foreign body sensation. 
Young sexually active pei'S()n typically, but can be found in nil age groups. 
Unilateral initially then bilateral2 to 3 days later by autoinoculation. 
Teat-y, gooey, and irritated eyes. 
Aching pain. 
May be photophobic if cornea is involved. 
Decrease in VA. 
References lJ. .l, N 
Objecti'r·e Findings of Hyperacute Bacterial Conjunctivitis 
In the beginning stages of the infection, the S)mptoms arc similar to those with acute 
conjunctivitis, but quickly progress to have greater involvement. 
Con,junctiva 
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Figure 10 
Pharmacological Treatment of Hyperacute Bacterial Conjunctivitis 
Caused by Neisseria without corneal Hk<er 
Caused by Neit.;:oeria with corneal ulcer 
Un~dentified pathogen 
Ocular discharge will cease within 24 to 48 hours with proper therapy. Other symptoms and 
signs will slowly resolve over· 7 to 14 days. 
If Gram stain id.entjfies a Neisseria. species pathogen and there is no 
corneal ulcer present, then t re2t disease as fcHows. 
Systemic medications 
Penidllin - the mainstay therapy. 
Amoxicillin/cluvnlanic acid -effective ugainst a number of gram -
negative and gram- positive microbes. 
Ceftt·iaxone- given as an 1M in,jection. 
Eo'tbrnmvcin 
Topical medications 
Fortified Gentamicin 
Preparation- add 2 ml (40 mg) of parenteral gentamicin into a 5- m1 bottle of 
commercially available gentamicin eye drops. The resultant solution contains 14 
mglml and is stable for up to 30 days. Administer drops every 30 minutes 
around tb.e clocl<. 
Adrninistt·ation 
Ciprofloucin 
0- 24 hours- one drop each eye every 30 minutes. 
After 24 bow· with improvement-- one dt·op each eye 
every two hours. 
After 48 hours with continued improvement- one 
drop each eye every three to four how·s. 
Aftet' 72 hours with continued improvement- one 
drop each eye until resolution. 
Preparation 
None. Available in 0.3% commercial concentration. 
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Figure 11 
trse the following topica~ antibiotics :vhC'H tn'n ting unid£ntificd pathogen 
1. G~ntamidn 
2. Tohnunvcin 
3 Ci~1·r•floxacin 
4. Norflnxndn 
S. Oflnxncin 
6. Polvtrim 
7. I'olvs~urin 
8. NcoS[!ol"in 
9. Bndtracin 
10. Ervthrmnvdn 
11. Chlnnun!1henicol 
Dosage- every 2 hours for two days in involved eye, then five times per day thereafter· until 
resolution. 
l?e{er~llces /) , F. 1·; .If,./, T. U 
Figure 12 
Gentamicin 
1'1·adt• n:1mc·.<: Genoptic (gtt), Gentacidin (gtt), Gat·amycin (gtt), Gentak (gtt) 
• . warning<~: Use in p1·egnant and nursing women should only occur when use is clearly needed and tbe benefits outweigh the 
risks to the fetus. 
Sr"ctrum of at·ti,·i t'! Primarily effective against gram-m·gatiw bacilli including Pseudomonas aeruginosa. See :also effectivities 
against gn•m-uosithcs and cntemh:~ch.•rhrccac, 
Mrrh~ n i'111 of ad inn: Inhibition of bacterial protein synthesis. 
i)osl': 0.3% solution and ointment suitable for treatment. Instill dt•ops to infected eye every 4 hours. Serious infections may be 
treated eve!)' 2 hours until improvement is seen. If using ointment, apply q4h for acute cases and bid or qhs for mild cases. 
Sid<• ('l"frcts; Toxic to cornea. Causes delayed epithelialization and punctate keratitis. 
Specili<·,: Resistance is developing including by Pseudomonas. Generally cross-resistance between gentamicin and tobramycin. 
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Conclusion 
This web site is aimed at providing the practicing optometrist 
and the optometric student with an informational reference source 
regarding ocular disease by using bacterial conjunctivitis as a 
template. The six main sections to the Bacterial Conjunctivitis Page 
are Main Page, Pharmacology Page, Diagnostic Technique Page, 
Differential Page, Bacterial Page, and Reference Page. They were 
established to provide the user an intuitive and quick means to 
locate specific information. 
As in all forms of ocular disease · bacterial conjunctivitis does 
not always present with a full compliment of the "classic" signs, the 
reference source includes as many of the signs and symptoms that 
could be reasonably found, however it is ultimately up to the 
individual practitioner to make the final clinical diagnosis. 
Information contained in this project relied heavily on current 
textbooks, class notes, and journal articles and has tried to represent 
the current state of knowledge on the topic of bacterial conjunctivitis. 
Further, all treatment options and protocols are presented to 
represent the standard of care, however as with the diagnosis it is 
ultimately the practitioner who defines the final treatment protocol. 
Some treatment regimes described in this project may be out of 
the scope of practice for optometrists in states with limited 
therapeutic coverage. We have tried to be as specific as possible in 
describing the management of those conditions that can be managed 
or co-managed by the optometrist. It is up to the individual 
optometrist to know the extent of therapeutics that they are allowed 
to use in their state of practice. Keep in mind that the therapeutic 
modalities detailed in the project are not inclusive to that particular 
disease but only the most common modality. Therefore, they are 
guidelines and not absolutes. 
It is beyond the scope of this project to list in detail all known 
information pertaining to the symptoms, signs, pharmacology, 
diagnostic techniques, differential diagnosis, and bacteria of bacterial 
conjunctivitis. Please consult additional sources of references if the 
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web page information IS unsatisfactory or if more information on a 
topic is required. 
We realize due to the magnitude of the project that errors, 
omissions and unintentional additions may exist. Even though we 
have endeavored to be as accurate, complete and concise as possible, 
we recommend that this project be used with additional sources of 
information and references when diagnosing and treating diseases, 
especially those that you are unfamiliar with. We therefore do not 
imply or accept professionally liability for the treatment of those 
conditions included in this web site. 
Although it is not possible for all information concermng 
bacterial conjunctivitis to be included, it is hoped that this web site is 
helpful to all who use it and we welcome any corrections or 
constructive input that can be incorporated into future updates. 
As all web browser's are not all exactly the same, there 1s 
always an inherent chance that this information will not be accessed 
by a particular user's browser. This will not be a problem for the 
vast majority of user's but it is still a problem might occur. 
All rights reserved 
Copyright 1997 
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Appendix 1 
Structural outline 
I. Main Page 
A. Etiology 
1. Acute bacterial conjunctivitis 
2. Hyperacute bacterial conjunctivitis 
3. Chronic bacterial conjunctivitis 
B. Epidemiology 
C General signs & symptoms of bacterial conjunctivitis 
D. Prevention of bacterial conjunctivitis 
1. Patients 
2. O.D.'s 
E Sources of Infection 
F. Natural Defense Mechanisms 
G Specific types of bacterial conjunctivitis 
1. Acute 
a. Causes 
b. Subjective Findings 
c. Objective Findings 
d. Treatment 
e. Follow-up 
2 . Hyperacute 
a. Causes 
b. Subjective Findings 
c. Objective Findings 
d. Treatment 
1 ). caused by Neisseria with corneal ulcer 
2) . caused by Neisseria without corneal ulcer 
3). unidentified pathogen 
e . Follow-up 
3. Chronic 
a. Causes 
b. Subjective Findings 
c. Objective Findings 
d. Diagnostic Tests 
e . Treatment 
f. Follow-up 
4. Neonatal 
a . Causes 
b . Subjective Findings 
c. Objective Findings 
d. Prophylaxis 
e. Treatment 
f. Follow-up 
II. Pharmacology Page 
A. Treatment protocols 
1. General 
B. Pharmaceutical indications 
1. General 
2. Specific for each individual drug 
C Pharmaceutical contraindications 
1. General 
2. Specific for each individual drug 
D. Pharmaceutical precautions 
1. General 
2. Specific for each individual drug 
E Pharmaceutical administration 
1. General 
F. Drug effectiveness 
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Etiology 
Tear film is compromised or deficient due to old age, bacterial toxins, immunocompromised or 
deficient. Both local and systemic disorders can undermine the conjunctiva of its defenses and 
create an opportunity for its infection. 
~: usually the result of the combination of a compromised defense 
mechanisms and the availability of an oppot·tunistic bacteria. 
Hyperacute: u:•ually spread to the eye by direct contact with secretions or 
infected urine, m· indirectly via the hands. 
Chronic: usually requires an adnexal source of bacteria and typically will 
resolve when this source is eliminated. Acute forms of conjunctivitis that last 
over 2 - 4 weeks are classified as chronic. 
Epidemiology 
A cotmnon infectious bacterial condition of the outer eye which can affect all ages, races, and genders in aU 
geographic regions. 
General signs and symptoms 
Acute onset of either unilateral or bilatenl burning and stickiness associated with a purulent discharge and 
hyperemic papillary conjunctival response with lid crusting and debris formation. Vision is initially clear unless 
keratitis supervenes, and this takes the form of punctate lesions involving the entire cornea. The severity of the 
infection depends to a certain extent on the pathogen responsible, the age ofthe individual, state of any inunune 
incompetence, whether or not any lid abnormalities are present, patient hygiene and nourishment, and 
cotmnunity conditions. 
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Re(ere11ces B. D. F. H. I. J, K, I\' 
Prevention 
Patients: 
l . Good lid and general hygiene 
2. Avoid contact with the conjunctiva during the acute process. Limit reinfection. 
3. Never use medications for more than 6 to 8 weeks. 
O.D.'s: 
1. Never patch a conjunctiviti~. 
2. Watch the cornea during the therapy sequence. 
3. Patients tend not come to foUow-up examinations; make sure that you keep track oftbem. 
Sources of infection 
Potential reservoirs for pathogenic organisms include the lids, conjunctiva, canaliculi, lacrimal sac, paranasal 
sinuses, upper respiratory tract, ears, skin and pelvic region. Other sources include contact lenses and their 
solutions, topical drops and mascara brushes. Given the pmper conditions, almost any bacteria can invade the 
conjunctiva. 
Rd"erencer A,N 
Natural defense mechanisms 
Epithelium and epithelial glycocalyx, lysoz)me, lactoferrin, antibodies, orosomucoid, betalysin, ceruloplasmin, 
immunoglobulins lgA and IgG, superoxide dysmutase, complement system, .PMN's, tear flow, blinking, mucus 
trapping and normal flora. 
Re(ere~u:es A, N, V 
Acute (mucopurulent) Bacterial Conjunctivitis 
Sobiective Findings/ Objective Findings/ Treatment/ Follow Up/ Causes 
SubjectiJ'e Filtding.v of Acute BaL·terial (onjunctivitis 
Main symptom i.~ patient concern with increasing redness. 
Found in all age groups. 
Unilateral initially then bilatera12 to 3 days later by autoinoculation. 
Teary and irritated eyes 
History of 2 to 3 days with increasing symptoms and signs. 
Foreign body sensation. 
Red eyes. 
Eyes stuck together in the morning. 
Little to no pain. 
Vision not affected. 
May have a history of upper respiratory infection (URI) or otitis media. 
Frequently associated history of bacterial blepharitis. 
Young, adult contact lenses wearer. 
References B. C. D. H. I, J. N 
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Objective Fi11dings of Acute Bacterial Conjuncti•titis 
Conjunctiva 
Bulbar 
Hyperemic and meaty red. Greater in fornix. 
Small to large papillae on tarsal conjunctiva. 
Circumcorneal area relatively clear. 
Injected blood vessels are movable. 
Small and large blood vessels involved. 
Small conjunctival petechial hemorrhages and ma1·ginal corneal infiltrates occur early in common with 
H influenzae infections. 
Palpebral 
Papillae of small to large size usually present. 
Often blanched and congested by secondary edema. 
Preauricular lymph node: 
Page 3 of18 
Lymphadenopathy is small or absent. Most bacteria and their by-products are primarily discharged from the ocular 
surface through the nasolacrimal drainage system, not through lymphatic drainage. 
Cornea: 
Can be clear or have diffuse superficial punctate staining (SPK). May be present during fll'st 2 to 3 days of infection and 
then gone by fourth. 
Marginal infiltrates in inferior cornea. 
S. aureus may produce peripheral corneal infiltrates, phlyctenulosis, and limbal nodules. 
Discharge: 
Is scarce and mucopurulent in nature. 
Will cause hard crusts on eyelashes and lid margins. 
Will make opening the eyes in the morning increasingly difficult. 
Will be yellowish to greenish in nature. 
Additional findings commonly seen in Acute Pediatric Bacterial Conjunctivitis 
Usually bilateral 
Purulent exudate. 
Concurrent otitis - the physician should also check for otitis in all pediatric patients with 
conjunctivitis even if symptoms are not present. 
Concurrent pharyngitis - the physician should also check for pharyngitis in all pediatric 
patients with conjunctivitis even if symptoms are not present. 
References B. C. D. II, I. J, AB 
Treatment of Acute Bacterial Conjunctivitis 
Without intervention- will generally go away by itself in 7 - 10 days but can progress to chronic. 
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With appropriate intervention- significant improvement in 12- 36 hours. 
Non-pharmacological 
1 . Lid hygiene- to remove debris. 
2. Warm compress- T.LD. m· Q.LD. especially in the morning to get eyelids open. 
3. Irrigation- Can use standard soft contact lens rinsing solutions to b·rigate as they contain anti-bacterial 
agents. This helps to wash out most of the bacteria and their toxins. 
References D.J.K 
Pharmacological 
Click here for specific phrumaceuticals to treat an identified pathogen m· use the following topical antibiotics 
when treating unidentified pathogen. 
Topical Antibiotic therapv-
1. Gentamicin 
2. Tobramycin 
3. Ciprofloxacin 
4. Nortloxacin 
5. Ot1oxacin 
6. Polytrim 
7. Polysporin 
8. Neosporin 
9. Bacitracin 
10. Ervthromycin 
11. Chloramphenicol 
12. Sulfacetarnide/ SuHisoxazole 
Dosage- usually 4 times a day for 7- 10 days 
Steroids or mixed antibiotic/steroids 
1. Avoid in mild to moderate, caution even in severe. 
2. Dosage- usually 4 times a day for 3- 5 days (7- 10 days max.) then taper. 
3. Monitor intra-ocular pressures (lOP's). 
Reference..~ D.F,H.I.J,N 
Follow-up for Treatment Q{ Acute Bacterial Conjunctivitis 
First {Olluw-up 
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1. If worse in 24 hours then return to clinic (RTC) OR if not better in 48 hours then RTC OR if not gone in 96 hours then 
RTC. 
2. Patient should RTC in 3- 5 days regardless of whether S)mptoms ru·e gone or not. 
Second {Ollow-up 
1. RTC in 1 week after f"rrst follow-up. 
2. Dismiss or reassess. 
/{eye gets worse with treatment then . ... 
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I . Rethink DDX OR 
2. Change medications OR 
3. Add oral medications OR 
4. Extend treatment OR 
5. Refer 
Reference.~ B,C,D.HJ,J.L 
Catue~· l~( Acute Baderial Conjunctivitis 
Bacteria 
G1·am+ wed 
S. aureus 
S. epidermidis 
S. pneumonia* 
S. pyogenes 
S. viridans 
Gram - bacilli 
M lacunata 
H. influenza* 
P. aeruginosa "* 
Coliform species 
Gram-cocci 
N. gonorrheae* * 
Chlamydiae: 
C. trachomatis*" 
*The major bacterial agents affecting pediatrics although all are pathogenic. 
* * Treatment should be aggressive if these sight threatening pathogens are suspected. 
Re(eretJces B. D. H. l, J, L, ,'f,f. N, AA 
Other top causes of Acute Bacterial Conjunctivitis: 
Adenovirus, allergic reaction, blepharoconjunctivitis, chlamydia), contact lens related reaction, 
dermatologically related conditions, drug induced, dry eye syndrome, epidemic 
keratoconjunctivitis, episcleritis, follicular types, foreign-body reaction, fungal conjunctivitis, 
giant papillary conjunctivitis, glaucoma, acute angle closure, herpes simplex, herpes zoster, 
hypersensitivity reaction, keratoconjunctiviti~, lid deformity which leads to corneal exposure, 
meibomian abscess, molluscum contagiosum, ocular rosacea, pharyngoconjunctival fever, 
phlyctenular reaction, pinguecula, scleritis, subconjunctival hemorrhage, systemic related 
(secondary to), tear f'tbn abnormalities, trichiasis, toxic reaction, sexually transmitted, and 
vernal keratoconjunctivitis 
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Click for diffenntial diaguosis of each condition. 
References B, D. II, I. J, L, N, 
~Return to Acute Bacterial Conjunctivitis 
l3 Return to Top of this Page 
9 Return to Bacterial Conjunctivitis Welcome Page 
Hyperacute Bacterial Conjunctivitis 
Subjective Findings! Objective Findings/ Treatment/ Follow U~/ Causes 
Subjective Findings of Hyperacute Bacterial Conjunctivitis 
Findings are similar to acute bacterial conjunctivitis but worse. 
First symptom is a foreign body sensation. 
Young sexually active person typically, but can be found in all age groups. 
Unilateral initially then bilate.-a12 to 3 days later by autoinoculation. 
Teary, gooey, and irritated eyes. 
Aching pain. 
May be photophobic if cornea is involved. 
Decrease in VA. 
Re(erenca If. J. N 
Objective Findings of Hyperacute Bacterial Conjunctivitis 
In the beginning stages of the infection, the symptoms are similar to those with acute 
conjunctivitis, but quickly progress to have greater involvement. 
Conjunctiva 
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Hemorrhagic conjunctival changes. 
Hyperemic, and meaty r·ed. Greater in fornix. 
Small to large papillae on tarsal conjunctiva. 
Injected blood vessels ar·e movable. 
Small and large blood vessels involved. 
Palpebral 
Hemorrhagic conjuncti~·al changes. 
Development of true m· pseudomembranes. 
Papillae. 
Preauricular lymph node 
Cornea 
Discharge 
Prominent and tender 
Toxic corneal staining 
Possible ulceration 
Copious purulent discharge 
Yellow-white to yellow-green in color 
Other Objective Hyperacute Findings 
Usually bilateral 
Upper and lower lid edema, erythema, and hyperemia 
Preseptal cellulitis may be concurrently present 
Tender adnexa 
Iridocyclitis in later stages 
Reference$ B, C. D, II, I, J. N, T 
Treatment of Hyperacute Bacterial Conjunctivitis 
Lab work-up is mandatory 
1. Culture 
Chocolate agar 
Thayer·-Martin selective media 
Fer·mentation studies 
2. Antibacterial drug sensitivities 
3. Gram and Giemsa stains 
4. Cytology 
If Gram - diplococci are identified, fermentation studies should be performed to distinguish 
between meningococcus and gonococcus. 
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It has been suggested that all cases of pediatric hyperacute conjunctivitis should be cultured and 
a Gram stain performed. Jf the Gram stain discloses gram-negative diplococci, initial therapy 
should include both systemic and topical antibiotic therapy. 
Notification of public health officials is mandatory. 
Frequent lavage of the lid and conjunctival sac is helpful in removing the purulent exudate. 
References II, I. N 
Pharmacological Treatment of Hyperacute Bacterial Conjunctivitis 
Caused by Nei.Y~eria without corneal ulcer 
Caused by Neisseria with corneal ulcer 
Unidentified path01en 
Ocular discharge will cease within 24 to 48 hours with proper therapy. Other symptoms and 
signs will slowly resoh'e over 7 to 14 days. 
If Gram stain identifies a Neisseria species pathogen and there is no 
corneal ulcer present, then treat disease as follows. 
Systemic medications 
Penicillin - the mainstay therapy. 
Amoxicillin/clavulanic acid - effective against a number of gram -
negative and gram - positive microbes. 
Ceftriaxone - given as an lM injection. 
Ervtbromvcin 
Topical medications 
FortirJed Gentamicin 
Preparation - add 2 mJ ( 40 mg) of parenteral gentamicin into a 5 - mJ bottle of 
commercially available gentamicin eye drops. The resultant solution contains 14 
mglml and is stable for up to 30 days. Administer drops every 30 minutes 
around the clock. 
Administration 
CiproOoxacin 
0- 24 hours - one drop each eye every 30 minutes. 
After 24 hour with improvement- one drop each eye 
every two hours. 
After 48 hours with continued improvement -- one 
drop each eye every three to four how·s. 
After· 72 hours with continued improvement- one 
drop each eye until resolution. 
Preparation 
None. Available in 0.3% commercial concentration. 
Administration 
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0- 6 hoW's- 2 drops each eye every 15 minutes. 
6 hours - •·ernainder of day -- 2 drops each eye every 30 
minutes. 
Day 1 - day 2 •• 2 drops each eye every hour. 
Day 2 to day 14 •• 2 drops each eye every 4 hours. 
Day 14 on·· At discretion of the treating clinician. 
C)cloplegics - 1 dmp each eye, three times per day. 
Atropine 1% 
Scopolamine 0.25% 
Cyclopentolate 1% 
If Gram stain identifies a Neisseria species pathogen and corneal ulcer 
is present then hospitalize patient for systemic ceftriaxone therapy. 
Systemic medications 
PeniciJiin - the mainstay therapy. 
AmoxiciUinldavulanic acid - effective against a number of gram -
negative and gram - positive microbes. 
Ceftdaxone - given as an 1M injection. 
En1hromycin 
Topical medications 
Bacitracin 
Gentamicin 
Ciprofioxacin 
Dosage- every 2 hours for two days in involved eye, then five times per day 
thereafter until resolution. 
Use the following topical antibiotics when treating unidentified pathogen 
1. Gt"ntamicin 
2. Tob.-amvcin 
3. Ciprofioxacin 
4. Norfioxacin 
5. Ofloxacin 
6. Pohtrinl 
7. Polysporin 
8. Neosporin 
9. Bacitracin 
10. En1hromycin 
11. Chloramphenicol 
Dosage- every 2 hours for two days in involved eye, then five times per day thereafter until 
resolution. 
References D. E. F. H. I, T, U 
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Follow-up for Treatment of Hyperacute Bacterial Conjunctivitis 
First follow-up 
1. If worse in 24 hours then return to clinic (RTC) OR if not better in 48 hours then RTC OR if 
not gone in 96 hom·s then RTC. 
2. Patient should RTC in 3- 5 days regardless of whether S)mptoms are gone or not. 
Second follow-up 
1. RTC in 1 week after nrst follow-up. 
2. Dismiss or reassess. 
If eye gets worse with treatment then .•.. 
1. Rethink DDX OR 
2. Change medications OR 
3. Add oral medications OR 
4. Extend treatment OR 
5. Refer 
Re(oences D. H 
Causes of Hyperacute Bacterial Conjunctivitis 
Bacteria 
Gram+ cocci 
Staphylococcus aureus 
Stt·eptococcus pneumoniae 
Gram - bacilli 
Pseudomonas aeruginosa 
Enterobacteria 
Escherichia coli 
Serratia marcesens 
Klebsiella pneumoniae 
Haemopbilus influenzae 
Haemophilus aegyptius 
Gram-cocci 
Neisseria gonorrheae -most common cause. 
Neisseria meningitidis 
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Branhamella catarrhali'l 
Acinetobacter calcoaceticus 
Gram + bacilli 
Bacillu~ of o.xlt>rll'in 
References D. II./, T 
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Chronic Bacterial Conjunctivitis 
Subiedive Flndin:sl Obiedive Findings 
Diagnotttlc THts/ Treatment/ FoJkm· Up/ Cames 
Chronic conjunctivitis bas many different etiologies ofwbich bacteria is one. As many of the normal flora of the 
ocular adnexa can be the bacterial cause of the disease, culturing is useful onJy after a detailed history has 
eliminated other causes (allergic, viral, chlamydial. .. ). Chronic conjunctivitis will be eliminated after its source 
is removed. 
Subjective Findings of Chronic Bacterial ConjunctiYitis: 
Persistent burning sensation 
Conjunctival injection 
Ocular discharge 
Re{ertmce.t H,l,N 
Objecth·c Findings of Chronic Bacterial Conjunctivitis 
Eyelids 
Conjunctiva 
Hyperemic and edematous eyelids. 
Madarosis. 
A crusted yellowish exudate may encase the base of the lash. 
Recurrent internal and external hordeola. 
Chalazion. 
Palpebral 
Mild to moderate hyperemia. 
Micropapillary hyperplasia 
Follicular hyperplasia may be observed in chronic M. 
lacunata infections. 
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Cornea 
Discharge 
Thickening. 
Mild to moderate hyperemia. 
Thickening. 
Fine, discrete punctate epithelial keratitis involving inferior 113. 
Marginal corneal ulcention involving infer-ior 113. 
Phlyctenules are uncommon. 
Micropannus. 
Subepithelial infiltrates. 
Lid matting in the morning 
Mild to moderate stringy mucous strands in fornices. 
References 8. H, I, lV, Z 
Diagnostic tests for Chronic Bacterial Conjunctivitis 
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Following the standardized testing routine below can identify the etiology of chronic conjunctivitis in 69-81% of the cases. 
A standardized questionnaire is completed fnr each patient to evaluate the following: demographic factors, medical history 
including history of systemic diseases, medications, exposure history, occupational history, allergic history, characteristics of the 
patient's ocular complaints, eyelid abnormalities, previous diagnostic studies, previous diagnosis and previous treatment. A 
complete externaJ examination of each eye including palpation of the preauricular and submandibular lymph nodes, evaluation 
of external and adnexal tissues, slit-lamp biomicroscopy of the anterior segment of the eye, presence of foreign bodies or irritants, 
Gram and Giemsa staining of conjunctival smears, application of fluorescein and rose bengal to the ocular surface, measurement 
of tear breakup time, and Schirmer's test with anesthesia. Further diagnostic tests are performed as nece..~sary. 
If bacteria, Chlamydia, or Herpes simplex I and ll are suspected to be the cause, perform diagnostic idf.'nti.fication test 
Treatment of Chronic Bacterial Conjunctivitis 
Preliminary diagnosis and treatment are based on the assessment at the patient's initial examination, which 
includes history, physical fmdings, and interpretation of routine cytological smears. Amend therapy if the 1·esults 
of microbiologic identification assays indicate an inappropriate initial therapy. 
If etiology of disease is determined to be bacterial then treat as follows: 
Education 
The patient needs to know that it is a chronic problem that may not be able to 
be completely cw·ed. The symptoms can be controlled but will probably never 
completely go away. 
Lid hygiene 
Involves hot comp1·esses and eyelid scrubs. This i<s probably the best long term 
treatment for managing the disease. 
Eyelid scrubs - Scrub the eyelids, margins and lashes using a 
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washcloth or a cotton-tipped applicator and a 50:50 solution of 
baby shampoo and warm water two times pet· day. 
Bot compresses - Soak a wa.<~hcloth in water that is as bot as the 
patient is able to withstand Place washcloth over the eyes for 
15 minutes. If the washcloth should cool down then resoak. 
This will bring blood to the eyelids and also loosen up the 
glands for mechanical expression. Do this one to two times per 
day. 
Artificial tears as needed. 
Referenc..s H, 0, Z 
Pharmacological Treatment of Chronic Bacterial ConjunctiYitis 
Add if S)mptoms are severe enough. 
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See phannaceutical page for specific phat·maceuticals to treat an identified pathogen or use the following topical 
antibiotics when treating unidentified pathogen. 
Topical Antibiotic therapy- ointment is preferential to drops. 
1. Gent-.unicin 
2. Tobramwin 
3.Polytrim 
4. Polysporin 
5. Neosporin 
6. Bacitracin 
7 .. Enthromycin 
8. Sulfacetamidt>/Sulfisoxazole 
Dosage- usually only at night for 7- 10 days 
Steroids or mixed antibiotic/steroids- avoid. Use only to treat secondary 
changes to the cornea. 
References D, F. fl. I, J. N 
Follow-up for Treatment of Chronic Bacterial Conjunctivitis 
2-4 days following initial visit: communicate results of diagnostic tests, assess response to treatment and alter 
therapy if necessary. 
One week after cessation of antibiotic treatment or two to three weeks after the initiation of long-term therapeutic 
intervention, re- assess patient. If there is improvement, back off initial therapy and prescribe maintenance 
therapy. Re-educate patient on his or her chronic condition. 
Re{ereR<".es f/, 0 
Causes of Chronic Bacterial Conjunctivitis 
Bacteiia 
Gram + cocci: 
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S. aureus 
S. epidermidis 
S. pneumonia"' 
S. pyogenes 
S. viridans 
Gnm - rods: 
H. influenza"' 
P. aeruginosa 
Coliform: 
Proteus mirabilis 
Klebsiella pneumoniae 
Serratia marcescens 
Escherichia coli 
Gram -cocci: 
N. gonorrheae 
M. lacunata 
Chlamydiae: 
C. trachomatis 
"'The major bacterial agents affecting pediatrics, although all are pathogenic. 
References II, I. J, M 
Other top causes of Chronic Bacterial Conjunctivitis 
Virus, irritant, allergen, contact lens and their solutions, acne rosacea, floppy eyelid syndrome, insect larvae, 
topical medications, cosmetics, soaps, and perfumes. 
Click for Differential Diagn~is information. 
References 0, AB .. •W 
::i2J Return to Chronic Bacterial Conjunctivitis 
..d Return to Top ofthi~ Page 
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Neonatal Bacterial Conjunctivitis (Ophthalmia Neonatorum) 
SuQjectiYc Findingl¥ OQjecthe Findings/ Propbylaxis/ Treatrlli.'ItV Follow Up! CaUSl.~ 
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Defined as a purulent discharge from the eyes occurring during the first 28 days of life. Occurs in 1.6% to 12% 
of neonates. 
Due to newborns being immunologically immature, any bacteria that causes conjunctivitis can progress to 
produce sepsis and a lethal outcome. 
References N, X. 1' 
Subjective Findings ofNeonatal Bacterial Conjunctivitis 
History of previous newborn with neonatal conjunctivitis. 
Mother who has not received prenatal care. 
Usually bilatenl 
Red eyes. 
Teary, gooey, and irritated eyes. 
May be photophobic if cornea is involved. 
Most severe symptoms occur with gonococcal or chlamydia) conjunctiviti~ . 
Re(erences R, C, D. H. I. J, l•'i: .Y, Y 
Objective Findings of Neonatal Bacterial Conjunctivitis 
Conjunctiva: 
Bulbar: 
Mild to severe hyperemia 
Chemosis. 
Small to large papillae on tarsal conjunctiva. 
lnjccted blood vessels are movable. 
Small and large blood vessels involved. 
Palpebral: 
Mild to severe hyperemia 
Development of true or pseudomembranes. 
Preauricular lymph node: 
Prominent and tender preauricular lymph node. 
Cornea: 
Toxic corneal staining. 
Possible ulceration. 
Discharge: 
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Scant mucoid to copious purulent discharge. 
Other: 
Systemic bacterial infection signs present. 
Usually bilateral. 
Upper and lower lid edema, erythema, and hyperemia. 
Pr·eseptal cellulitis may be concurrently present. 
Tender adnexa. 
Iridocyclitis in later stages. 
References B. C. D, H. I. J, N, 1; .Y. 1' 
Prophylaxis 
Prophylactic drops should be given to the newborn no later than one hour after birth. 
Gonococcal 
1. 1% silver nitrate - causes a chemical conjunctivitis that appear·s on the first 
day and disappears spontaneously within 3 to 4 days. 
2. Erythromycin or tetracycline ung. 
Chlamydia!: 
1. Erythromycin or tetracycline ung -should be prophylactic for chlamydia 
although no studies have shown effectiveness against neonatal chlamydia! 
conjunctivitis. 
References 1>. X. Y 
Treatment of Neonatal Bacterial Conjunctivitis 
Lab studies are mandatory. 
Gram stain of di<~charge. 
Examination of a Giemsa-stained conjunctival scrapings. 
Cultures. 
Systemic involvement is not uncommon and is serious when present. 
Topical 
Bacitracin ung 
En1hromycin ung 
Tetracycline 
Gentamicin gtt 
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Systemic 
ceftriaxone 
General differential guidelines 
Age !Leading Cause Treatment 
Oto5 ~nococcus Systemic ceftriaxonc: 50mgfl<Wday admini<rtered IV or 1M for 7days; lavage days infant's eves hourly; treat parents. Rule out N. meningitidls with lab studies. 
5 days to Chlamydia Oral Erythromycin: 50mglkgl day given as divided doses 2 or 4 times/day 5wks or 14 days; topical therapy of '! value; treat parents 
5wks to Streptococcus Bacitracin ung or Erythromycin ung alternated with gentamicin sol every 2 
5 yrs brs. H influenzae 
~yrs 
Staphylococcu~ !Bacitracin ung or Et'}ihromycin ung alternated with gentamicin sol every 2 and lbrs. ~lder 
Re{ere~IC& D. X Y 
Follow-up for Treatment of Neonatal Bacterial Conjunctivitis 
First follow-up 
I . If worse in 24 hours then return to clinic (R TC) OR if not better in 48 hours then RTC OR if not 
gone in 96 hours then R TC . 
2 . Patient should R TC in 3 - 5 days regardless of whether symptoms are gone or not. 
Second follow-up 
1. RTC in l week after flrst follow-up. 
2 . Dismiss or reassess. 
If eye gets worse with treatment then . . . 
I . Rethink DDX OR 
2. Change medications OR 
3. Add or change oral medications OR 
4 . Extend treatment OR 
5. Refer. 
Re[ernrce..~ D. H 
Causes of Neonatal Bacterial Conjunctivitis 
Bacteria 
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Practically every known bacterial species has been seen to be a cause of bacterial neonatal conjunctivitis. Below is a list of 
some of the more common bacterial pathogens. 
Bacterial Conjunctivitis Main Page 
Gram+ cocci 
S. aureus 
S. epidermidis 
S. pnewnonia 
S. pyogenes 
Gram- rods 
H. influenza 
P. aeruginosa 
Enterobacteria 
Gram- cocci 
N. gonorrheae* 
N. meningitidis 
B. catarrhalis 
Chlamydiae: 
C. trachomatis* 
*Are the major bacterial agents although all arc pathogenic. 
References D, .\·. Y 
Other top causes of Neonatal Bacterial Conjunctivitis 
Chemical, viral, trawna, allergic, foreign body, lid deformity, systemic causes, and trichiasis. 
Re(eences Y, .-tB, .W 
G::::l Return to Neonatal Bacterial Conjuoctivitis 
~ Retum to Top of this Page 
~Return to Bacterial Conjunctivitis Welcome Page 
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Bacterial Conjunctivitis- Pharmacology Page 1 oflO 
Pharmacology 
Initial treatment should be an antibiotic with broad antibacterial coverage until the specific 
etiological organism is identified. 
Causes of failure to respond to antibacterial treatment 
Resistant bacteria, lid infection, inflammation, tumors. lid deformity, tear film abnormalities, ocular rosacea, atopy, 
dacryocystitis, canaliculitis, foreign body, vims infection, inclusion conjunctivitis, self inllicted, compromised host and 
opporturristic infection. Rd B 
Systemic antibiotic regime to use in the e\'·ent of failu~ of topical treatment 
Bacteria Type Vru1:. of choice 
Gram+ 
Staph t'Ioxacillin + Flucidin 
!Benzylpenicillin 
Strep 
fMethicillin t·esi~tant then use Rifampin or Vancon~ 
Gram- Gentamicin 
H Beta Lactamase negativf Ceftazidime 
H Beta Lactamase Piperacillin B posifue 
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Indications 
For the treatment ofbacterial conjunctivitis. 
Contraindications 
Hypersensitivity to any component of the formulation. 
Epitlielial herpes simplex keratitis, vaccinia, varicella, mycobacterial :infections or fungal diseases of the ocular 
struc-ture. 
Precautions 
Deep-seated ocular inlections or those that are likely to become systemic. 
Long 1\-'Till use may result in bacterial or fungaJ overgrowth of non-susceptible organi-.ms. 
Administration 
When instilling dmps _ 
1. Check expiration date and then shake bottle. 
2. Tilt head back and place medication in inferior conjunctival cul-de-sac. 
3. Close eyes and apply pressure on the lacrimal sac for 1 minute following instillation to facilitate drug 
absorption into eye. 
4. Avoid contaminating bottle by not touching tip to any surface and replacing cap after instillation of 
medication. 
\vllen instilling ointment 
1. Check expiration date. 
2. Squeeze out 0.5 em of ointment onto clean fingL'Ttip and discard. 
3. Squeeze out 0.5 to 1.0 em of ointment on fmgertip. 
4. Place ointment in inferior cul-de-sac and blink normally. 
Terminology 
drop(s) = gt(t) 
ointment = ung 
solution = sol 
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Drug Effectivities against Gram Positive Bacteria 
E = Effective 
RES= Some resistant strains 
PROPH = Used prophylactically 
Staph 'if f. oureus ~_trey sp P, pneumooiae t'-virld!l115 grOUf Be!n hemolytic 51rep P- ~t'lle! 
&c;_rtraGin 1!. IE IR E E It 
"flllll"dl" E IE K E 
~~B 
Erythromycin ~ IRES RES 
!"); E E • nmr-thl)jlmn :r. E E 
Norlloxodn E :'It E 
9E_rclloxa~in JL IR E 'E E 
KJflaxocin E IE E .I E 
Neom)'tin !E 
Gen:tamicin lil RES RES .RE& E 
Tobro111ffGin :E 1t IL E E 
'?._ulfacet_amide_ E .1!. E E R 
!:>_ulfa>Q>atole E :E. 1!. E 'E 
Polytrim ~ E 1!. E 
Pol~jlorin E E E E 
Nm5fN!ril IE E 
Drug Effectivities against Gram Negative Bacteria 
E =Effective 
RES =Some resistmd .~trains 
PRO PH= Used praphyltu.1ically 
tioemophilus influenza Nei55eria 51 N. gonorrboe<Je ~orox.efla s ~dll~Q:!]~ 
Bacitracin E E 
Gramicidin 
Pohtnt:1111in B E 
' 
E 
E~romv~ln r. J'ROPH 
Cbloramphen_k:QJ E II: E 
Trimethoorim I E 
Norfloxacin E E B 
CiPiofloxacln E IF. E E 
Oflo.ucfn E E E E 
Neomvcin IE E I 
Gentamicin )!: E E li: RES 
l obra""'cln E IE E E 
Sulfacetamide E 
-
S_ulfasoxazole 
PoMrim E E 
PolwDOI'in E K Jt 
IN.eos~n 1!. E E 
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Drug Effectivities against Enterobacteriaceae 
E =Effective 
RES =Some resistant straim: 
PROPH = Used prophylacticaUy 
"- r;d 
i Kl~sie !lo ~~ K:. jW!Umooi"' Prot€115 ~ IEnterooocter Sf IE-aeragenes tserTatia m~r&e'iCEfl'i 
aaci~acin 
Gramicidin 
-Polvmvxin B E E IE 
Ervthromvcin 
Chloramohenico £ E 1!. 
Trimethoorim E 1!. E E R 
Norfloxacin E 1!. E )!; E ~ IS 
Ciorofloxacin It E E J! R It E 
IOffoxacin It E E 1!. E IE E 
Neomllcin ]! E E E 
Gentamicin E E R E E II!. 
ITobrn_mvcm E 1!. E E E E 
Sulfacetamide E E £ E 
SUifatoxazole K 1!. E E 
Polvtrlm lt E E 
Po1vsoorin IE E 
Neosl:12[in E IE E 
Bacitracin 
Typically found in mncentrations of500 units/gin ophthalmological ointments. Used singularly or in combination with uther 
antibiotics. 
Trade names: Baciquent (ung), Bacitracin (ung), and AK-Tracin {ung) 
Spt•ctrum of acthity: Primar ily e.ram-po~itive organisms. Click for t!.l'Rffi ne!!l!tive and entcn.•har.terinceut· acth-ity. 
Mechuni.<im of actiun: Inhibits cell wall ~·ynthesi~. A bactericidal drug. 
Do~e: 
Acute: <J4h initially then reduce treatment to q6-8h. 
Mild: Apply bid. 
Side effects: Rarely causes adverse effects but contact dermatiti'i has been reported. 
Specifi,-s: Stable only in ointment form. 
Gramicidin 
Trad<-' nam('-S: Gramicidin. Also found in combination solutions taking the place of bacitracin like l'oeospol"in. 
Specn·um of 11ctnity: Gram Positive. Gram Ne:;:;11tivc., Emerobactel"lacene 
Admini~tration : See instructions above for procedure to instill solution. 
Mt'Chani-.m of action: Disrupts cytoplasmic membrane. 
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Side <"ITN:ts: Rarely causes any. 
Polymyxin B 
Used topically in combination with other antibiotics and steroids as it is not commercially available as a stand alone drug. 
Trade names: In combination- Pulysporin (uog), Neosporin (ung). Cortisporin (ung), Maxitrol (gtt), and Terramycin (gtt). 
SpPctrum of acth·ity: Primarily gram-negative bacilli Clic){ here for Gram Positin and EntC"fobacterlaccoc spectrums of activity. 
Mechan~m of action: Disrupts cytoplasmic membrane. A bactericidal drug. 
Sidt• effect'l: 
l . Systemic: Neurotoxicity- dixliness, ataxia. mu..<1cular weakness, and nephrotoxicily. Rarely used systemically. 
2 . Topical: Ruely causes side effects. Sometimes causes irritation and/or allergic reactions. 
Combination: 
Ointments-
l. Polyspurin: Polymyxin B-Bacitracin 
2. Neosporin: Polymyxin B-Bacitracin- Neomycin 
3. Cortisporin: Polymyxin B- Neomycin- Bacitracin- Hydrocortisone 
Drops-
1. Maxitrol: Polymyxin B- Neomycin- Dexamethasone 
2. Terramycin w/ Polymyxin B: Polymyxin B-OX)1etracydine 
Et=yth romycin 
Tradt> mum-s: Erythromycin (ung), AK-Mycin(gtt.), and IJotycin(gtt). 
Spt>ctrum of activity~ Primarily effective against gn~m-poslttve organisms. Gr•11m-nrgath•c coverage i~ limited to N. gonorrhcae, N. 
meningitidis, and H. influenzae. Drug is primarily bacteriostatic. There is a possibility that drug could be bactericidal in high 
concentrations. Not effective against Enterobnctet'iaceue. 
Mech11.nism of action: Inhibition of bacterial protein synthesis. Bacteriostatic drug. 
Bacterial conjunctivitis: Apply q2h then reduce treatment for acute cases; for mild cases, apply bid, to qhs. 
Neonatal gonococcal prophylaxi'i: Apply a thin line of0.5% Erytht·omycin ointment 0.5 to 1.0 em in length to infant's 
inferior conjunctival sac. Administer a new tube to aU newborns. 1% Silver nitrate !iOlution or 1% tetracycline can al'!O 
be used for prophylaxis. If mother of child has clinically significant gonmThea, give IV or 1M injections of penicillin G to 
infant. 
Side ell"eds: Allergic reaction.'i.. 
Chloramphenicol 
Tradt> niUJM'S: Chloramphenicol (nng, !iOl), AK-Chlor (ung, !iOI), Chloromycetin (nng), and Chloroptic S.O.P. (1mg). 
Spt'Ctrum of acthity: A broad-spectrum drug. Is eft'ective in treating a wide ~·ariety of gram-positive and grum-negatiw bacteria. 
See also spectrum of activity against enterobacter~iaceae. 
Mechanism of acti4m: Inhibition of bacterial protein synthesis. A bacteriostatic dmg. 
Indication.-.: A u se only in severe or life-threatening infections where less toxic drugs han pronn to be ineffective or 
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contraindicated. Drug of Ia.~t chok:e. St-1.' Sitle Effcd~ ~low. 
Dooe: 
Ointment: A ' 'ailablc in 1.0% concentration. Place 0.5 l"lll in inferior cul-d~ac(s) every 3 how·s, day and uight for the 
first 481JOu:rs. In severe infections, shorten interval between applications. After 4!i hours increase the interval between 
applications and continue to use until 48 hours after signs of infection are gone. 
Solution: Available in 0.5% concentration. Instill 1 or 2 drops every 4 to 6 hours for tlrst 72 hours depending upon the 
severity of the infection. After 48 hours increase the interval between applications and continue to use until48 boors 
after signs ofinfet:tion are gone. 
Side effel'"t-.: (both systemic and topical) 
Aplastic anemia 
l. Not dose dependent 
2. Irreversible. 
3. Can occur following completion of therapy. 
4. Can be fatal. 
Bone marrow depression 
1. Dose related 
2. Reversible 
Neurologic complications including optic neuropathy. 
Gastrointestinal problems. 
Tdmethoprim 
Available in combination ~ith Po~myxin B under the trade name polytrim. 
Spectrum of acmity: EtTective against aerobic gram-positive bacteria. See also cft"ecti.vities against f!rllm-ncgatiH~s and 
![llterobadcri.aceoe, 
Mechanism of :u:tiun: Inhibition of protein synthesis. As Trimethoprim inhibits a different step in the pathway of protein 
synthesis than sulfonamides, both drugs can be used together synergi.<itically. 
Dose: 1 tu 2 drops bid to qid for 7 to 10 days. 
Side effects: Since the drug inhibits its production, folinic acid should be given concurrently to prevent anemia and WBC 
depression. Allergic reactions can occur. 
Combinations: Poly1rim: Trimetboprim-Pulymyxin B (effeliive as a broad spedrum combination a.<~ Polymyxin B is effective 
against Pseudomonas while Trimethoprim is not) 
Fluoroquinolones 
N ortloxacin 
Re(D,E.F. G 
Trade names: Cbibroxin (gtt) 
A warnings: Use in pregnant and nursing women should only occur when U.'iC in clearly needed and the benefits outweigh the 
risks to the fetus_ Can cause an occasional fatal hypersensitivity reaction in patients that have received systemic Norfloxacin 
medication. Only a few patients bad a history of bypersensifuity reactions. 
Specn·um of al"th ity: Broad spectrum (both 1!.fttm· P!I!Iitive and gntm neg~tth'e, including Pseudomonas) 
1\ft'Cb:.tni'lm of action: Inhibits balierial DNA synthesis 
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U!W: Norfloxacin .is appro\·ed for use in children one year of age and older. 
Dose: Depend in~ upon the severity of the condition, 1 to 2 gtt to infected eye(s) q 2 to 4 h for 2 d then QID for up to 5 days. Do not 
take dairy products, antacids or iron preparations within one hom· of taking medication. 
Side efft>ds: Discomfort on instillation, foreign bndy sensation, itching bitter taste following instillation. 
Adwr~ Reactions: Conjunctival hyperemia, chemosis, photophobia, bitter taste in mouth. 
Patient Information: Discontinue use and notify prescribing doctor at the first sign of a skin r·ash or other allergic reaction. 
Ciprotloxacin 
RetD.E.F,G 
Trade names: Ciloxan (gtt) 
A warnings: Use in pregnant and nursing women should onJy occur when use in clearly needed and the benefit'~ outweigh the 
risb to the fetus. Benefits to mother must be determined in order to decide if nursing should be discontinued or· mother taken off 
Ciprotloxacin. Can cause au occasional fatal h::nJerscnsith•ity reaction in patient'l that have 1·eceind systemic Ciprofloxacin 
medication. OnJy a few patients had a history of hypersensitivity reactions. 
Spectrum of acm·ity~ Bt"Oad spectrum (both gram-por~itive and gram ncl!!ltlve, including Pseudomonas). 
Mechanism of ac:lin11: Inhibits bacterial. DNA synthesi'> 
U~: Approved for use for patients over 12 years of age. 
Dose: Depending upon the severit;y of the conditinn, 1 to 2 gtt to infected eyc(s) q 2 tu 4 h for 2 d then QID for up to 5 days. Do not 
take dairy product'l, antacids nr iron pt·eparations within one hour of taking medication. Flush eyes with water· in cases of 
overdose. 
Sidl' effects: Discomfort on instillation., foreign body sensation, itching, bitter taste following instillation, drowsineM. 
Adverse t"<":tctions: White crystalline precipitates, lid margin ct·usting, crystals/scales, conjunctival hypet·emia, dermatopathy, 
allergic reactions, nausea, decreased vision. 
Patient Information: Di'lc:ontinue use and notify prescribing doctor at the fli'St sign of a skin rash or other allergic reaction. 
Ofloxacin 
Re[D.E, 1--; G 
Trade names: Ocutlox (gtt) 
A warnings: Use in pregnant and nursing women should only occur wben use in clearly needed and the benefits outweigh the 
risks to the fetus. Can cause an occasional fatal hypersensitivity reat:tiun in patients that have received systemic Ofloxacin 
medication. Only a few patients bad a history of hypersensitivity reactions. 
Spet·trum of activi~ : Broad spectrum (both graun-positlve and gram neg11tive, including Pseudomonas). 
Mecbani"Jm of acti.on: Inhibits bacterial DNA synthesis 
~ Depending upon the severity of the condition, 1 to 2 gtt to infected eye(s) q 2 to 4 h for 2 d then QID for up to 5 days. Do not 
take dairy product'l, antacid'i or iron preparation within one hom· of taking medication. 
Side efli.>cts: Discomfort on instillation, fureign body sensation, itching bitter taste following instillation. 
Adwt·se rt>actions: Tearing, photophobia, dryness 
Patient lnform11tioo: Discontinue use and notify prescribing doctor at the first sign of a skin rash or other allergic reaction. 
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Aminoglycosides 
Neomycin 
Trade narn~>.s: Usually seen in combination 'vith other drugs. The names of topical drugs containing neomycin are Neosporin 
(ung), Cortisporin (gtt), and Maxitrol (gtt). 
Spectrum of activity: Gt·am·positive. gram·nrnativt', enwmt~ctcl"iacl'al'. 
Mt>chantim of action: Inhibition of bacterial protein synthesis. Resistance is common. 
t:>o.w: 1 to 2 drops bid to qid for 7 to Hl days. 
Side effc~:ts: Topical application can cause a contact allergic readion in the form of a superficial keratitis., conjunctivitis, 
dermatitis 
Topical Combinations: 
1. Neosporin: Neomycin-Polymyxin B-Bacih·acin 
2. Cortispodn: N(!Omycin-Polymyxin B-Hydrocorti~one 
3 . MaxitroJ: Neomycin-Polymyxin B-Dexametbasone 
Specifics: Pseudomonas is not sensitive to neomycin. Product"l containing neomycin also include Polymyxin B. 
Gentamicin 
Trade names: Genopti.c (gtt), Genta.cidin (gtt) , Garamycin (gtt), Gentak (gtt) 
A warnings: Use in pregnant and nursing women should only occur when use is clearly needed and the benefits outweigh the 
risks to the fetus.. 
Spectrum. of activit)~ Primarily effedive against cyam-negattn•: bacilli including Pseudomonas aeruginosa. See also eftectivities 
against g,ram-PQllitivcs and enterobactcrlarcac. 
Mechanism of actiun: Inhibition of bacterial protein synthesis. 
Dos..•: 0.3"/o solution and ointment suitable for treatment Instill drops to infected eye every 4 hours. Serious infedions may he 
treated e\·ery 2 hours until improvement is seen. If using ointment, apply q4h for acute ca."lCS and bid or qhs for mild cases. 
Side eff(ds: Toxic to cornea. Causes delayed epithelialization and punctate keratitis. 
SpecifiC'S: Resistance is developing including by Pseudomnnas. Generally cross-resistance between gentamicin and tobramycin. 
Tobramycin 
Tradc names: Tobrex (gtt & ung), AK-Tob(gtt), 
A warnings: Use in pregnant and nursing women should only occur when use in clearly needed and the benefits outweigh the 
risks to the fetus.. Benefits to mother must be determined in order to decide if nursing should be discontinued or mother taken off 
of Tobramycin. 
Spectrum of activit}: Primarily effective against gram-negative bacilli including P. aeruginosa. See also effectivitics against 
gpmt-positives and enteroblteteriaccae. 
Mechani"lm of action: Inhibition of bacterial protein synthesis. 
Bacterial Conjunctivitis - Pb...'illllacology Page 9 oflO 
Do~e: 0.3°/o solution and ointment suitable for treatment Instill drops to infected eye every 4 hours. Serious infed.ions may be 
treated every 2 hours until.improvementis seen. If using ointment, apply q4h for acute cases and bid or qhs for mild cases. 
Overdosage may cause punctate keratiti'!, er·ythema, increased lacrimation, edema and lid itching. 
Sidt' •·nt·rts: Toxic to cornea and conjunctiva- causes delayed epithelialization, corneal ulceration, punctate keratitis and 
conjunctival hyperemia and chemosi~. 
Sptdtk<: Generally cr·oss-resistance between gentamicin and tobramycin. 
Sulfa -based Drugs 
Sodium Sulfacetamide 
Trade n:~me:s: 
Ointments: 
10%: AK-Suu·, Bleph-10, Cetam.ide, and Sodium Sulamyd. 
Solutions: 
10%: AK-Sulf, Bleph-10, Ocusulf-10, Sodium Sulamyd, and Sulf-10 
15%: Isopto Cetamide 
30%: Sodium Sulamyd 
A warnings: Use in pregnant and nursing women should only occur when use in clearly needed and the benefit.. ouhlo·eigh the 
risks to the fetus. Benefits to 111<lther mtut be determined in order to decide if nursing should be discontinued ur mother taken off 
of Sodium Sulfacetamide. Do not use in infants under 2 months of age. 
Spt>ctrum of acth·icy: Broad spectrum of activity with widespread resistance. See W'IIOI-J)!fflit.ive. w·arn-ncgath·e, and 
cuterobactcriacellc effecth'ities. 
Mechani.liffi of :u:tion: Jnhibi.tion of bacterial protein synthesis uf folic acid. A bacteriostatic drug. As Sodium Sulfacetamide 
inhibits a different step in the pathway of protein synthesis than Trimetboprim, both drugs can he used together synergistically. 
U<Oe: Use in less se''ere forms of bacterial conj tmdiviti~. 
Dos<-: Depending on the se'·erity of the infection, inst.illl to 2 drops of solution every 1 to 3 bow-s or ointment 1 to 4 times daily 
and at bedtime to infected eye. 
Sidr cffl'<-· t~: Be aware that there is a low incidence of hyper-sensitivity reactions (contact dermatitis) in the general population to 
sulfite containing medications. May cause corncall"pithelial healing to be retarded, conjundival edema, readive hyperemia, local 
photosensiti:r.ation. increa<ied burning and stinging with increased concentration, and myopia 
Specifks: Since humans get folic add from their diet, medication does a fleet the body's level of this protein. Do not use with silver 
preparations. Sulfa based drugs arc inhibited by local anesthetics and pus. 
Sulfisoxazole 
Tra~dc names: Gantri<~in 4% (grt) 
A warnings: Use in pr·egnant and nursing women should only occw· when usc in clearly needed and the benefits outweigh the 
risks to the fetus. Benefits to mother must be determined in order to decide if nursing should be discontinued or mother taken off 
of So Uisox.azole. Do not u.w in. infants under 2 months of age. 
Spectl'Um of acm'i~ : Broad spectrum of acm'ity with widespread resi~tancc. See w:am-witjYe, gram-negative. and 
cntcrobactetiaccat" efTectivities. 
Mechanism of :~ction: lnhihition of bacterial protein synthesis of folic acid. As Sullisoxazole inhibits a ditTerent step in the 
pathway of protein synthesi~ than Tr.imethoprim., both drugs can be used together synergistically. 
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Dose: Dependin~ on the severity of the infection, instill solution every 1 to 3 hours or ointment 1 to 4 times daily and at bedtime to 
infected eye. 
Side ~:fl'et:ls: Be awar·e that there is a low incidence of hyper-sensitivity reactions (contact dermatitis) in the general population to 
sulfite containing medications. May cause cor·neal epithelial healing to be retarded, conjuncth·al edema, r·eactive hyperemia, local 
photosensitization, increa~ burning and stinging with increased concentration, and myopia 
Sp(·cific$: Since hwnans get folic acid from their diet, medication does a1Tect the body's level of this protein. Do not use with silver 
preparations. Sulfa based drugs are inhibited by local anfStbetics and pus. 
Polytrin1 
Components: Pol}myxin B-Trimethoprim 
Click to see information on Polymyxin B or Trinwthopritn. 
Polysporin 
Fonn: Ointment 
Component-.: Bacitracin-Polymyxin B 
Dose: Apply q3-6h for 7 to 10 days. 
<..1ick to see information on Badtn.cb1 or Polymyxin B. 
Neosporin 
Forms: Ointment and Solution. 
Compon~;nts: 
Ointment: Bacitra.cin-Neomycin-Pol:ymyxiu B 
Solution: Grarnicidin-Neomycin-Polymyxin B 
Ointment: Apply q3-6h for 7 to 10 days. 
Solution: 1 to 2 drops bid to qid for 7 to 10 days. 
Click to see information on BacitJ·al'in, Gnmicidin, Neomvcin. or Pobmy:Un B. 
Penicillins 
fuhlbit bacterial cell wall syntb~;.~i~. 
A family of drugs; not a specific drug. 
Rarely used topically as they induce allergic readions. 
:3 Return to the Too of this Page 
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Bacteria causing Conjunctivitis 
(illun_::__cocci/ GtaJ1L± bar-lUI/ Chlamydiae/ Identification Techniques & Diagnostic Tests 
Classification 
Spherical- C<XCUS, COCCI 
Rod-shaped" bacillus, bacilli 
Spiral-shaped- spirillum, spirilla 
Gram stain -Reaction to gram stain divides bacteria into two groups 
Purplt>- positive 
Pink- negative 
Bacteria of Normal conjunctiva 
S. epidennidis 
S. aureus 
aerobic diptheroids* 
H. influenzae* 
Gastroenteric bacteria* 
PeptostreptOC<JCCus 
Propionibacterium acnes 
Lactobacillus species 
Haemophilus species 
Moraxella species 
*Thought to be transient in nature 
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Bacteria causing Conjunctivitis 
Descriptions o(Pathologic Bacteria 
Gram+ cocci: Staphylococcus species and Streptococcus species 
St<!pbylococcus species; S. aureus. S. Epidermidis 
.S..aureus 
1 . Most common cause of conjunctivitis 
2. Gmm-positive cocci arranged in irregular clusters 
3. Ocular .infections: blepharitis, conjunctivitis, corneal ulcers, cellulitis 
4. Systemic infectious: skin abscesses, impetigo, \Votmd infections, pneumonia, enterotoxin food 
poisoning, toxic-shock syndrome 
l. Probably the most common cause of conjunctivitis in the western world. 
2. Affects all age groups. 
3. May resolve spontaneously or progress to a chronic infection. 
S. epjdNrnidis 
1 . Contaminates cosmetics which in turn commonly caw~e conjlmcti'.l'itis. 
Streptococcus species; S. pneumonia. S. pyogenes. S. v:iridaos 
I.. G.ram positive cocci., arranged in chains or pairs 
2. Ocular infections: conjuncti"V'itis, corneal ulcers 
Page 2 of4 
3. Systemic iniections : pneumonia, sore throat, scarlet fever, erysipelas, impetigo, pncrJleral fever, wound and bum infections, 
rheumatic tever, glomerulonephritis, subacute endocarditis, "flesh-eating bacteria"- necrotizing .fasciitis and myositis. 
S. pneumoniae 
l . Found in upper respimtmy 1rdCt. 
2. Found mostly in preschool and grm<rr school children and in parents of these children. 
S.pyogencs 
l . Rarely causes a severe conjunctivitis \vith inilarn.ed membrane formation. 
S. viridans 
l . Normal flora ofthe upper respiratory tract. 
Gram- rod 
Haemophilus species, Moraxella species, and Coliform species 
IJ.a.em.Qp..hilus species: H. inlluenza .• J I. aegypl ius 
l . Systemic infections: meningitis, otitis media, respiratory infections 
2 . Somewhat (&1idious, aerobic bacteria with pleomorphic characteristics (look like slender rods). 
3. Cause small conjunctival petechial hemorrhages and marginal corneal infiltrates to occur early. 
4 . Found in upper respiratory tract. 
Bacteria causing Conjunctivitis 
5. Found more in clril.dren than adults. 
6. Strains ca.u:,'ing conjunctivitis not so virulent. 
Moraxella spcde_<;;Jyl. lacunata 
1. Large, aerobic diplolxJI.,-illi. 
2. Some &-pcc:ies constitute normal !lora on the mucous membranes. 
3. A COilll1l.O.J) cause of angular conjunctivitis (although S. aureus is the more common ca.u~e). 
4. Can also cause a chronic diplobact1lary conjunctivitis with folliculm- hypertrophy that does not evok.e a purulent r~se . 
.culirorm spc:::cies: Adnetobacter ralcoaceticus, Proteus species, Klebsiella pneumonia e. s_err:aJ.i.a_ 
marcescens 
1 . Enteric bacte:Iia. 
2. More common in older adults. 
3. A less common cause of disease than Staph, Strep, or H . influenza. 
Gram- cocci: Neisset·ia species 
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Nei.sseriJ species: N. gounrrheae. N. meoingitidis. N. catarrhalis, N. sjcca and Branhamell a catarrhalis 
l . Gram-negative diplococci usually inside PMN's 
2. Ocular infections: byperacute, purulent conjunctivitis-= invade healthy and uncompromised tissue. Can result in comcal 
peri.Oration. 
3. Systemic infections: gonorrhea 
N. gonorrheae 
1 . Very pathogenic. 
2. Causes neonatal conjunctivitis. Usually acquired from an infected mother during birthing process. 
3. Adults probably seU~inoculate 1hernselves from the genital region. 
N. meningitidis 
l . Very pathogenic. 
2. Clinical course identical to that ofN. gonorrheae but typically bas a milder course ·with less eomeal involvement 
3. CatL~es infrequent but serious cases of conjuncti>i.tis. 
4 . Causes meningococcemia if it gets into bloodstream. 
N. catarrhalis and N. sh:ca 
1. Typically non-pathogenic, but (lccasionally cau.~e chronic conjunctivitis. 
2 . Are frequently isolated from normal oropharyn.'X. 
Rranhamella catarrhalis 
1. Found in the upper respiratory tract. 
2. Ivfuy be mi:;;taken for meningococci. 
3. frequently produce~ beta-lactamase. 
J\cinetobacrer cakoaceticus 
1 . Causes acute and chronic conjunctivitis. 
2 . A culture lli needed to distinguish from Neisseriac. 
Bacteria causing Conjunctivitis 
Gram+ Bacilli 
Chla.rnydiae 
Bacillus of Doderlein 
Gram + S'j)OTe fortn.ing, aerobic, motile or nonmotile rod shaped bacteria that is 
sometimC'S found in chains. Usually non-pathogenic. 
Listeria monocytogenes 
Lives in soil and becomes pathogenic tbr hmnans under favorable conditions ~uch as 
pregnancy, immunosuppression, or extreme age. Most ccnnmonly causes meningitis 
in humans. 
Chlamydia trachomatis 
Intracellular parasites 
Most common sex.'rullly transmitted path.ogt:n. 
Ocular infections may progress to trachoma-like scarring. 
Re{erences B. C. 1<; M. IJ. M.l>l.OP.O.UJ( 
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Bacterial Conjunctivitis - L:>lfferential Diagn ... 
Adenovirus 
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History of upper r~pirat11ry infection, mild visual fluctuations, watery discharge, and lymph node enlarg"'Illent. Can compronuse 
natural defense mechanisms of eye and ID>JlOse conjunctiva to pathological bacteria. 
ANergic 
Itchell! Personal or fumily history of allergies. mucus discharge is stringy, frcqu\,'n.t seasonal relationship, und <mscl in bourn or days. 
BlepharoconjunctMtis 
Lidq edt.,-matous, hyperemic, w.td tender. Inferior punctate erosiom-1 along lid margins. 
Chlamydia 
An obligate intracellular lxu:teria, produces a combination of baderial and viral symptoms and signs. ~-ually active adults with a new 
partner in prc-viou-; 2- 3 months. Can compromise natuml dcfctL'>C mechani~>ms of eye and expose conjunctiva to pathological lxu:teria. 
Click here for Chlamydial Diagnostic test. 
Contact lens related reaction 
Redness, burning, and itching soon aftm-lens insertimL CHant PapiUarv ConiunctivitiM 
Drug induced 
Reactions ofti.'Il occur to prcs"nmives in eye drops causing marked hyperemia and a line papillary reactioa Other rcactious Ol..'l":ur to 
prolonged use of topical antibiotics or antivirals, causing a conjunctival papillary reaction, keratinization, or punctal slenob'is. 
Dry eye s.vndrome 
Abnonnal tear ftlm, torcign body sensation, !>tringy mucus, tram-ient blurring of vision, low Schirmer's test, and 51ainit1g defects. 
Punctate erosions of the conjunctiva and/or comea in the mid zone of the interpalpebral ftasure. 
Epidemic keratoconjunctiviti.f 
Acute follicular conjunctivitis, burning, initation, photophobia, preauricular Lymph.-li.k-'11opathy and corneal involvement Got it ti:om 
someone else. 
Episcleritis 
Deep injection (enlarged blood Veiisels will not move '-\-ith Q-tip), mild pain, and no discharge. 
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Foreign-body re(U1ion 
Hist\n:y oftbrcign material in eye, iorcign lxxl} ob:!erved on wnjunctiva and/or cornea. Trading detect;; observed on the conj·unctiva 
and/or cornea. 
f'ungal conjundlvitU 
More conunon in WHnll, humid climates. History of agricultural ocular injury, producing intense hyperemia and comefd C<k'll:w and 
necrosis. 
(iiant papillary conjunctivitis 
Usually associated with solt contact lenses wc:.w. Itching upon f\.."WOVal oflenses !'upiii.rn: on superior lid. Blucry "ision. 
(i/aueoma, acute angle closure 
Red eye, photophobic, nausea, vomiting, elevated lOP, and mid-dilated pupil. 
Herpes .5implex 
Skin lesions adjact-'llt to eye, acute follicular wnjunctivitis, preauricular l}mphadcnopalhy, punctate epithelial ewsion, and dendritic 
epithelial .keratitis. Can. compromise natural de tense m~.han-ihms of eye and espose conjunctiva to pathological bacteria. Click here for 
Herpes simplex Diagnootic Test. 
Ht!l'pe.fi water 
Vesicles on lid. pW.n, follicular conjunctivitis, papillary conjunctivitis, punctate epithelial keratitis, and decreased anterior corneal 
sen..'lation. Can compromise natural deft..'llJW mechanisms of eye and ex--pose conjunctiva to pathological bacteria. 
Jl.vpersensitivity reac/Wn 
Itching, unilateral (cont~ttypes) or bilak,•ral (cxog~.o'llous), fluctuating vision, pink to red bulb!lr conjunctiva, and stringy discharge. 
Kerat.oeonjunctivitis 
Will have bacterial conjunctivitis symptoms and sign along with the cornea[ presentation of lack of epithelium, stromal thinning, 
infiltration undt."f and around ule\."f, and edema. 
Lid deformity which leads to cornefll expo.fure 
Punctate erosions n~ually over the lower one to two thirds of the comea 
Molluscum t:ontagi.o.fium 
Chmnic follicular conjuncti\'itis not associated with lymphadt."'lopathy. Usually seen in adolescents and young adults with molluscum 
lesion on lid. 
Oculiu rosacea 
Chronic mcibom.ia.uitis and r~urrent chalw.ja, Keratitis in 5% ol' cases 
Phal'}wgoconjunctival fever 
Generally childrert History of pharyngitis, low grade ti..-ver and fi:>Uic'dar conjunctivitis. Rect..'llt swimming pool and/or hot tub exposure 
i.~commoiL 
Phlyctenular reaction 
Pinkish-white bulbar nodule, surrounding hyperemia. and a soft, necrotic center wiU fom1 and mough. 
Pinguecula 
Long ;;tanding hi.r:>tory oflN, outdoor, wind, and/or dry climate. Patient will usually notice it for the fi.r:st time when it bcwmc.'l 
inflamed Will report as "acute OlJ.S\.,1". A slightly elevated oval or trir.mguJar n:mss v.-ith baae toward limbus and nexi to, but not on, the 
cornea. 
Scleritis 
Inflammation of scleral, episclerld, and conjunctival blood ve.'!Sel:!, mild to e:-.1reme puin, ood patient hibiory of rbeumott>id anhritis. 
Sexually Transmitted Disease (S11J) 
Take a det.'rikd 1x:rsonal history to dek"tllline if patient bas aJJ STD, has changed scx'U.1l partners re~ently, and perfonn STD Slv'feCoing 
test 
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Subconjunctival hemorrhage 
An "eye bruise". Patient may or may not have a history oftrauma, valsclva"lilu; maneuvers, or r,·y!.1cuuc causes. Usually unilateral 
presentation of tlat sheets of unifom1 red blood with .no vessel pattcms observed. 
Systemic related (Secondary ttJ) 
Kuwa..<iaki diwase- an acute, febrile childhood disea..~ rHembling ~arlrt fewr. Patient pre.wntll with fever, 
lethargy, bJ•igbt red oral. mucosa, and bilatt.-ral conjum:tival congntion. 
Leptospinl!lis- 110 infection with the !lpirocbete Leptortpira. 
Stcvens-Jobll50n's ~')'Ddronw: Gt>neraUy young healthy males. Papillary conjunctivitis kading to 
pseudomembrane formatiDn. 
Tear film abntJrma/ities 
lncrease in mucu;; strands and debris, low Tear Brettk Up Time, ccmcavll or ab!K'llt marginal tear meniscus. 
Trichiasis 
Confirm DDX ""ith slit L.1mp exam. 
Toxic reaction 
Conjunctivul hemorrahages and chemosis. Alkali bums mtty cause oomplcte bl~mcbing of e<mjunctiva due to destruction ofhlood 
vessels. 
Vernal K er«U~eanjunctivitis 
Intense itdliug. rccum.'llt, fumil.ial history of allergy, seasonal, burning, photop!Jobia. uud stringy mucous r.tisc;harge . 
.Re(aencn B. C. D, F, H. I, J. K. L 
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When to culture? 
Microbial cultures are indicated when clinical findings are insufficient to arri"'e at a diagnosis, when the tissue reaction is sc"'cre, 
or when the infection has not responded to treatment in ~ suitable time. Indications for culturing include: 
1. Hyperacute conjunctiviti~ 
2. Neonatal conj1mctivitis (ophthabnia neonatorum) 
3 . Post-ope~·ative conjunctivitis and/or infections, e.g. cndophthabniti~. 
4. Chronic conjunt:tivitis 
5. Central corneal ulcers 
6. Membranous or pseudomembr anous conjunctivitis 
7 . Prescptal or orbital cellulitis 
8. Post-traumatic infections 
Media Types 
Blood Agar - Blood agar is the most commonly nsed medium as it will support the growth of most bacteria. 
Neisseria and Hacmophilus do not grow weD on blood agar, however. 
Chocolate Agar- Used for Neisseria and Haemophilus identification. 
Thayer-Martin Agar- Used for gonococcal isolation. 
Mannitol Salt Agar- Used to differentiate between S. epidermidis and S. aureus. S. aureus can ferment the sugar, 
manoito~ turning the pink agar yellow, whereas S. epidermidis cannot 
Sabouraud's Agar- Used for fungal isolation. 
MacConkev Agar- Contains bile salts and crystal violet which inhibit the growth uf gram-positive bacteria. Thi~ 
medium also contains lactose, and thus gram-negative bacteria that can grow on lactose can be differentiated 
Diagnostic Tests 
from those that t~annot 
How to take samples 
To compare normal to pathogenic flora, both eyes should be cultured. Whenever possible, specimens should 
be directly inoculated onto the solid media and promptly delivered to 1he lab. When tbi<; is not feasible, 
transport media such as the Cultun::tte can be used to keep the bacteria viable wtil the sample is plated by 
the lab. The Culi:Jm,'1te contains Stuart's medium for transporting specimens. 
Obey allwiversal precautions to prevent infecting yourself or other patients. 
Cultures should be taken befOre the instillation of anesthetics (exception: cornea. culture) or antibiotics, as 
these reduce the number of bacteria in the eye. If antibiotic therapy has already begun, it is necessary to 
discontinue the antibiotic at least I day before culturing. 
Eyelid Culture Procedure 
1. Clean away any t.Tusts or debris from the lid margins 
2. Moisten a cotton swab with unpreserved saline. 
3. Pun the lid away from the eye and wipe along the margin of the eyelid. Ron the ~'Wab along the lid 
ma.·gin three or four times so that it absm·bs some material 
4. Immediately inoculate the media plates. 
5. Using the swab from the right eye, place the swab on the agar surface in the lower left quadrant of the 
plate and slowly streak a capital "R". Material from the left eyelid is streaked as a capital "1." in the 
lower right quadrant of the plat('. Ron the applicator along the surface oftbe plate. Do not let the 
applica.tor dig into the plate or break the surface. Use a. separate ~'Wa.b for each sample. 
6. Label the sample with the patient's name, doctot·'s name, time and date of sample. 
Conjunctival Culture Procedure 
I . The inferior palpebral conjunctiva is the usual site for obtaining conjnnctival specimens. Evert the lower 
lid, pulling it down and away from the eye. 
2. Gentl.Y ron a moistened applicator along the entire inferior palpebral conjund:iva. Allow the applicator 
to absorb as much material as possible. Do not rub the conjunctiva and a'•oid touching the applicator to 
the lashes, lid margins, or yow· rmgers. 
3. Jmmediately streak a vertical zig-zag pattern in the top left quadrant of the medium plate for the right 
conjunctiva, and top right quadrant tor the left conjunctiva. 
Corneal Culture Procedure 
1. Instill a topical ophthalmic anesthetic in each eye. 
2. Using an alcohol lamp, propane torch, or Bunsen burner, flame a Kimura platinum spatula, heating it 
for senral seconds and allowing it to air· cool 
3. Focus on the ulcer using a slit lamp and place the spatula temporally and tangential!} to the mnteal 
lesion. Provide a suita.ble fixation object for the patient 
4. Using the edge of the spatula, gently scrape the advancing edge and then the ulcer hfd, .removing mll.fy 
fhe surfal.-c ceUs. The ;Advancing edge and ulcer bed are separate samples, being plated separately. 
Always move the spatula in a downward motion away from the eye. 
5. Take multiple samples of both areas of the ulcer, flaming the spatula after cub sampling. Place the first 
sample on slides for Gram and Giemsa staining. Next, inoculate blood, chocolltte, and Sal.muruud'~ agat' 
plates by lightly streaking the spatula over the sur face. 1\-lake a minimum of two rows of "C's" with each 
"C" representing a separate sample. Label the plates. Because of the relatively small number of 
recoverable bacteria, transport media are not used for corneal ulcer cultures. 
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Identification Tests 
Catalase Test 
Used to differentiate Staphylococci from Streptococci The Staphylococci produce catalase which converts hydrogen peroxide to 
water and oxygen. The oxygen will be seen as bubbles when the staph are exposed to hydrogen peroxide. 
Coagulase Test 
Used to differentiateS. aureus from S. cpidermidis. S. aureus is coagula.~ positive; that is, it produces an enzyme that has the 
ability to form a clot in normal uncoagulated plasma. S. epiderm.idi'> is coagulase negative. 
Bacterial antibiotics sensitivity studies 
Discs containing antibiotic:\\ are placed on the blood agar plates once the growth of the microorganisms bas been identifie(l The 
zones of growth inhibition around each di'IC arc measured, indicating each antibiotit:'s eflbcthitj'. 
Diagnostic identification tests JO£ Chlamydia and Herpes simplex virus land II. 
im;tiU a topical anesthetic and S'Wab inferior and superior palpebral conjunctiva of each eye with S'Wabs prewetted with 
Schaedler's bmth. To test for Chlamydia, ron a swab onto slides for a dire<.1: immunufluorest."ent mollllndomd lint~[,.,, :;:,- . 
test ~nd th<:>n pi";:" in Ch!arnydial transport m<..'ilia. To test for Herpes simplex virn .. <~ types I and ll, roll another swab onto slides 
J(lr a direct immunofluorescent monoclonal antibody staining t.est ll.lld th:en place in vi:ra~ ln mspm1 moo~;;. 
:<o; !J""~ 1<>·· <lk;..;"t ~'l•mimo1luooescent monoclonal antihody staining are air-dried and then rtxed with water-fi·ee acetone. Slides are 
then refi·igerated at 4 C and proces.'ied within 48 hours. A total mf30nll of fi'lliOr<.."s<;:em·-nu~jll!gat.;;d 1r"' '" ,, .. ·i;,,._;, ,,.,.,,;-.,, ,,: '"' 
<r:tL:mydi ;;. cr;- l-:-:-, ;:r,; ;;imp!cx ~it·us t".fpes 1 and II are then pipetted onto the approp1·ate specimen. which is kept within a 
humidified chamber at room temperature fur IS minutes., l'insed with watec;, and a:ir-dtie..t ~.:;s;f!~:·." -... _, ... ~ ··~ •.-·.;: .• , .. "'":· . .. ,·'!": ···'' ·•· 
;:;c;,!er .;; jl jr;;n;.: : ,;iim hy flt;.;:>;-c-scent microswpy. A specimen was considered positive for Chlamydia if three or more typkal 
elementary bodies were identified and positive for heqlCS simplex via·ill.s if one or mor>e <.t~,;;. . .:i ;,,d;','''' '"· ., .. ,., •. F.i"·~=< 
Cblamydial transport vials are then immediately fro.zen to -70 C. Specimens are thawed within 48 botH s !!nd i.lw;:.!tb e;olu ·'''Ill~"'' 
~::·-:~~~~-~~ :~:·•~~~.,.~~~~._1 Mt:Coy cell monulayers in microtiter plates as previously described. One set of duplicate wells are stained 
at two days (tirst passage), and another set passed at twu days ten. stained at four days (secomll pa:>c•>.!!~>!'·~ wid;! 
tluorescein-conjnated monoclonal antibody to Chlamydia. Specimens are examined at X400 magnification and scored positive if 
one or more typical inclusion bodies are found 
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